Feng Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Feng Wang has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Ying Su
Eye Hospital, The First Affiliated Hospital, Harbin Medical University, Harbin, China
10 shared publications Ying Su
Eye Hospital, the First Affiliated Hospital, Harbin Medical University, Harbin, P R China
9 shared publications- Ying Su
Department of Ophthalmology, the First Affiliated Hospital, Harbin Medical University, Harbin, China
4 shared publications Kexin Liu
Department of Ophthalmology, the Fourth Affiliated Hospital, Harbin Medical University, Harbin, P R China
3 shared publicationsHuazhang Li
Department of Ophthalmology, The Fourth Affiliated Hospital, Harbin Medical University, Harbin, China
2 shared publications- Kexin Liu
Department of Ophthalmology, The Fourth Affiliated Hospital, Harbin Medical University, Harbin, China
2 shared publications
Latest Publications
- 20 May 2026
- Published by Elsevier in International Immunopharmacology
- Vol. 183, 116863
Mechanosensitive ion channel TRPV4 inhibition alleviates glaucomatous inflammation by regulating microglial ferroptosis
- 20 May 2026
- Published by Elsevier in International Immunopharmacology
- Vol. 183, 116863
Mechanosensitive ion channel TRPV4 inhibition alleviates glaucomatous inflammation by regulating microglial ferroptosis
- Open Access
- 24 November 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 41644
The TRPV4-YAP axis mediates cytoskeletal and extracellular matrix remodeling in trabecular meshwork cells as a novel glaucoma mechanism
Transient Receptor Potential Vanilloid 4 (TRPV4), a non-selective cation channel in trabecular meshwork (TM) tissue, is activated by forces like deformation and shear stress, playing a critical role in intraocular pressure (IOP) regulation. However, the mechanisms by which TRPV4 mediates TM cells responses to elevated intraocular pressure (IOP), along with the resulting regulatory outcomes, remain incompletely understood. In vitro, TM cells were mechanically stretched, and the effects on TRPV4 activation and calcium influx were evaluated via confocal microscopy, Western blotting, and immunofluorescence. Pharmacological agonists and inhibitors were used to investigate signaling mechanisms. In vivo, ocular hypertension (OHT) was induced in mice, and IOP was measured following drug treatments. Subsequently, IOP was measured after drug administration. Transcriptome sequencing was performed to detect TRPV4 activation-induced alterations in RNA expression and to explore associated regulatory pathways. Mechanical stretch significantly reduced YAP1 mRNA expression in TM cells. TRPV4 activation induced YAP nuclear translocation, which was inhibited by HC067047, confirming TRPV4-YAP signaling. Transcriptome sequencing confirmed that the PI3K/AKT signaling pathway is crucial in mediating YAP activation. In vivo, HC067047 and VP treatment significantly lowered IOP and reduced the accumulation of ECM proteins in TM tissues. Our study demonstrates the critical role of TRPV4-YAP signaling in TM cell function and IOP regulation. These findings indicate that targeting the TRPV4-PI3K/AKT-YAP axis may offer novel therapeutic strategies for glaucoma.
- 24 November 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 41644
Open AccessThe TRPV4-YAP axis mediates cytoskeletal and extracellular matrix remodeling in trabecular meshwork cells as a novel glaucoma mechanism
Transient Receptor Potential Vanilloid 4 (TRPV4), a non-selective cation channel in trabecular meshwork (TM) tissue, is activated by forces like deformation and shear stress, playing a critical role in intraocular pressure (IOP) regulation. However, the mechanisms by which TRPV4 mediates TM cells responses to elevated intraocular pressure (IOP), along with the resulting regulatory outcomes, remain incompletely understood. In vitro, TM cells were mechanically stretched, and the effects on TRPV4 activation and calcium influx were evaluated via confocal microscopy, Western blotting, and immunofluorescence. Pharmacological agonists and inhibitors were used to investigate signaling mechanisms. In vivo, ocular hypertension (OHT) was induced in mice, and IOP was measured following drug treatments. Subsequently, IOP was measured after drug administration. Transcriptome sequencing was performed to detect TRPV4 activation-induced alterations in RNA expression and to explore associated regulatory pathways. Mechanical stretch significantly reduced YAP1 mRNA expression in TM cells. TRPV4 activation induced YAP nuclear translocation, which was inhibited by HC067047, confirming TRPV4-YAP signaling. Transcriptome sequencing confirmed that the PI3K/AKT signaling pathway is crucial in mediating YAP activation. In vivo, HC067047 and VP treatment significantly lowered IOP and reduced the accumulation of ECM proteins in TM tissues. Our study demonstrates the critical role of TRPV4-YAP signaling in TM cell function and IOP regulation. These findings indicate that targeting the TRPV4-PI3K/AKT-YAP axis may offer novel therapeutic strategies for glaucoma.
- Open Access
- 2 June 2025
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 66 (6) , 47
NR4A1 Alleviates Subretinal Fibrosis by Inhibiting Macrophage to Myofibroblast Transition
Subretinal fibrosis (SF) secondary to neovascular age-related macular degeneration (nAMD) is the most predominant cause of central visual impairment in all patients with AMD. NR4A1 is a member of the nuclear orphan receptor superfamily, and has shown inhibitory effects on fibrosis in tissues such as the dermis, intestines, and heart. Cytosporone B (Csn-B) is a natural agonist of NR4A1. This study aims to explore whether NR4A1 plays a role in SF associated with nAMD. Mice RPE-choroid-sclera flat mounts were prepared for serial observation of changes in macrophage infiltration, as well as macrophage to myofibroblast transformation (MMT). The morphology of MMT cells and differences in extracellular matrix (ECM) expression were further observed in TGF-β1-induced THP-1 cells. The role of NR4A1 in MMT was confirmed by small interfering RNA (siRNA) after changes in NR4A1 were observed. To determine whether NR4A1 could be a target for SF treatment, we intervened with the Csn-B and observed the MMT and SF changes. Macrophages were rapidly recruited in the early stage and gradually decreased after the second week. MMT was observed in the lesions and the maximum number of MMT cells was observed at the third week. NR4A1 was transiently upregulated with induction, followed by a gradual decrease and a continuous phosphorylation. The knockdown of NR4A1 promoted MMT and ECM expression, whereas treatment with Csn-B had an inhibitory effect. P-NR4A1 expression was significantly suppressed in Csn-B-treated MMT cells. Finally, MK-2206 was found to inhibit sustained TGF-β1-induced NR4A1 phosphorylation and also ECM expression. NR4A1 inhibits MMT and reduces ECM deposition in SF. Its agonist Csn-B inhibits MMT by inhibiting AKT-induced NR4A1 phosphorylation, which then attenuates SF.
- 2 June 2025
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 66 (6) , 47
Open AccessNR4A1 Alleviates Subretinal Fibrosis by Inhibiting Macrophage to Myofibroblast Transition
Subretinal fibrosis (SF) secondary to neovascular age-related macular degeneration (nAMD) is the most predominant cause of central visual impairment in all patients with AMD. NR4A1 is a member of the nuclear orphan receptor superfamily, and has shown inhibitory effects on fibrosis in tissues such as the dermis, intestines, and heart. Cytosporone B (Csn-B) is a natural agonist of NR4A1. This study aims to explore whether NR4A1 plays a role in SF associated with nAMD. Mice RPE-choroid-sclera flat mounts were prepared for serial observation of changes in macrophage infiltration, as well as macrophage to myofibroblast transformation (MMT). The morphology of MMT cells and differences in extracellular matrix (ECM) expression were further observed in TGF-β1-induced THP-1 cells. The role of NR4A1 in MMT was confirmed by small interfering RNA (siRNA) after changes in NR4A1 were observed. To determine whether NR4A1 could be a target for SF treatment, we intervened with the Csn-B and observed the MMT and SF changes. Macrophages were rapidly recruited in the early stage and gradually decreased after the second week. MMT was observed in the lesions and the maximum number of MMT cells was observed at the third week. NR4A1 was transiently upregulated with induction, followed by a gradual decrease and a continuous phosphorylation. The knockdown of NR4A1 promoted MMT and ECM expression, whereas treatment with Csn-B had an inhibitory effect. P-NR4A1 expression was significantly suppressed in Csn-B-treated MMT cells. Finally, MK-2206 was found to inhibit sustained TGF-β1-induced NR4A1 phosphorylation and also ECM expression. NR4A1 inhibits MMT and reduces ECM deposition in SF. Its agonist Csn-B inhibits MMT by inhibiting AKT-induced NR4A1 phosphorylation, which then attenuates SF.
- 24 March 2025
- Published by Springer Nature in Human Cell
- Vol. 38 (3) , 1-14
Advances in the study of single-walled carbon nanotubes in ophthalmology
With the rapid development of nanotechnology, the application of nanomaterials in the medical field shows unprecedented potential and innovative prospects. In particular, single-walled carbon nanotubes (SWCNTs), due to their unique physicochemical properties such as high surface area, excellent thermal and electrical properties, high surface/volume aspect ratio, and high tensile strength, show great potential for application in biomedical and biotechnological fields. Ophthalmology, as a branch of medicine that requires great precision and innovation, is gradually becoming one of the hotspots for nanotechnology applications. Although the research and application of nanomaterials in ophthalmology have made some progress, the potential of SWCNTs in ophthalmology has not yet been explored. This paper is a comprehensive review of the applications of nanomaterials in ophthalmology, including their use in drug delivery, antimicrobials, imaging, tissue repair, and photodynamic therapy, and further explores the similar roles of SWCNTs in other medical fields, thus speculating on their potentially important value in ophthalmic research.
- 24 March 2025
- Published by Springer Nature in Human Cell
- Vol. 38 (3) , 1-14
Advances in the study of single-walled carbon nanotubes in ophthalmology
With the rapid development of nanotechnology, the application of nanomaterials in the medical field shows unprecedented potential and innovative prospects. In particular, single-walled carbon nanotubes (SWCNTs), due to their unique physicochemical properties such as high surface area, excellent thermal and electrical properties, high surface/volume aspect ratio, and high tensile strength, show great potential for application in biomedical and biotechnological fields. Ophthalmology, as a branch of medicine that requires great precision and innovation, is gradually becoming one of the hotspots for nanotechnology applications. Although the research and application of nanomaterials in ophthalmology have made some progress, the potential of SWCNTs in ophthalmology has not yet been explored. This paper is a comprehensive review of the applications of nanomaterials in ophthalmology, including their use in drug delivery, antimicrobials, imaging, tissue repair, and photodynamic therapy, and further explores the similar roles of SWCNTs in other medical fields, thus speculating on their potentially important value in ophthalmic research.
- 18 November 2024
- Published by Elsevier in Experimental Eye Research
- Vol. 250, 110153
Role of semaphorin7A in epithelial-mesenchymal transition and proliferative vitreoretinopathy
- 18 November 2024
- Published by Elsevier in Experimental Eye Research
- Vol. 250, 110153
Role of semaphorin7A in epithelial-mesenchymal transition and proliferative vitreoretinopathy
- 2 August 2024
- Published by Springer Nature in Human Cell
- Vol. 37 (5) , 1336-1346
Carbon quantum dots for the diagnosis and treatment of ophthalmic diseases
Carbon quantum dots (CQDs), an emerging nanomaterial, are gaining attention in ophthalmological applications due to their distinctive physical, chemical, and biological characteristics. For example, their inherent fluorescent capabilities offer a novel and promising alternative to conventional fluorescent dyes for ocular disease diagnostics. Furthermore, because of the excellent biocompatibility and minimal cytotoxicity, CQDs are well-suited for therapeutic applications. In addition, functionalized CQDs can effectively deliver drugs to the posterior part of the eyeball to inhibit neovascularization. This review details the use of CQDs in the management of ophthalmic diseases, including various retinal diseases, and ocular infections. While still in its initial phases within ophthalmology, the significant potential of CQDs for diagnosing and treating eye conditions is evident. Graphical abstract
- 2 August 2024
- Published by Springer Nature in Human Cell
- Vol. 37 (5) , 1336-1346
Carbon quantum dots for the diagnosis and treatment of ophthalmic diseases
Carbon quantum dots (CQDs), an emerging nanomaterial, are gaining attention in ophthalmological applications due to their distinctive physical, chemical, and biological characteristics. For example, their inherent fluorescent capabilities offer a novel and promising alternative to conventional fluorescent dyes for ocular disease diagnostics. Furthermore, because of the excellent biocompatibility and minimal cytotoxicity, CQDs are well-suited for therapeutic applications. In addition, functionalized CQDs can effectively deliver drugs to the posterior part of the eyeball to inhibit neovascularization. This review details the use of CQDs in the management of ophthalmic diseases, including various retinal diseases, and ocular infections. While still in its initial phases within ophthalmology, the significant potential of CQDs for diagnosing and treating eye conditions is evident. Graphical abstract
- 5 February 2024
- Published by Springer Nature in Human Cell
- Vol. 37 (2) , 394-407
Role of mechanically-sensitive cation channels Piezo1 and TRPV4 in trabecular meshwork cell mechanotransduction
Glaucoma is one of the leading causes of irreversible blindness in developed countries, and intraocular pressure (IOP) is primary and only treatable risk factor, suggesting that to a significant extent, glaucoma is a disease of IOP disorder and pathological mechanotransduction. IOP-lowering ways are limited to decreaseing aqueous humour (AH) production or increasing the uveoscleral outflow pathway. Still, therapeutic approaches have been lacking to control IOP by enhancing the trabecular meshwork (TM) pathway. Trabecular meshwork cells (TMCs) have endothelial and myofibroblast properties and are responsible for the renewal of the extracellular matrix (ECM). Mechanosensitive cation channels, including Piezo1 and TRPV4, are abundantly expressed in primary TMCs and trigger mechanostress-dependent ECM and cytoskeletal remodelling. However, prolonged mechanical stimulation severely affects cellular biosynthesis through TMC mechanotransduction, including signaling, gene expression, ECM remodelling, and cytoskeletal structural changes, involving outflow facilities and elevating IOP. As for the functional coupling relationship between Piezo1 and TRPV4 channels, inspired by VECs and osteoblasts, we hypothesized that Piezo1 may also act upstream of TRPV4 in glaucomatous TM tissue, mediating the activation of TRPV4 via Ca2+ inflow or Ca2+ binding to phospholipase A2(PLA2), and thus be involved in increasing TM outflow resistance and elevated IOP. Therefore, this review aims to help identify new potential targets for IOP stabilization in ocular hypertension and primary open-angle glaucoma by understanding the mechanical transduction mechanisms associated with the development of glaucoma and may provide ideas into novel treatments for preventing the progression of glaucoma by targeting mechanotransduction.
- 5 February 2024
- Published by Springer Nature in Human Cell
- Vol. 37 (2) , 394-407
Role of mechanically-sensitive cation channels Piezo1 and TRPV4 in trabecular meshwork cell mechanotransduction
Glaucoma is one of the leading causes of irreversible blindness in developed countries, and intraocular pressure (IOP) is primary and only treatable risk factor, suggesting that to a significant extent, glaucoma is a disease of IOP disorder and pathological mechanotransduction. IOP-lowering ways are limited to decreaseing aqueous humour (AH) production or increasing the uveoscleral outflow pathway. Still, therapeutic approaches have been lacking to control IOP by enhancing the trabecular meshwork (TM) pathway. Trabecular meshwork cells (TMCs) have endothelial and myofibroblast properties and are responsible for the renewal of the extracellular matrix (ECM). Mechanosensitive cation channels, including Piezo1 and TRPV4, are abundantly expressed in primary TMCs and trigger mechanostress-dependent ECM and cytoskeletal remodelling. However, prolonged mechanical stimulation severely affects cellular biosynthesis through TMC mechanotransduction, including signaling, gene expression, ECM remodelling, and cytoskeletal structural changes, involving outflow facilities and elevating IOP. As for the functional coupling relationship between Piezo1 and TRPV4 channels, inspired by VECs and osteoblasts, we hypothesized that Piezo1 may also act upstream of TRPV4 in glaucomatous TM tissue, mediating the activation of TRPV4 via Ca2+ inflow or Ca2+ binding to phospholipase A2(PLA2), and thus be involved in increasing TM outflow resistance and elevated IOP. Therefore, this review aims to help identify new potential targets for IOP stabilization in ocular hypertension and primary open-angle glaucoma by understanding the mechanical transduction mechanisms associated with the development of glaucoma and may provide ideas into novel treatments for preventing the progression of glaucoma by targeting mechanotransduction.
- 8 January 2024
- Published by Elsevier in Experimental Eye Research
- Vol. 239, 109784
TRPV: An emerging target in glaucoma and optic nerve damage
- 8 January 2024
- Published by Elsevier in Experimental Eye Research
- Vol. 239, 109784
TRPV: An emerging target in glaucoma and optic nerve damage
- 13 March 2023
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 478 (12) , 2683-2693
Cuproptosis and its application in different cancers: an overview
Heavy metal ions are essential micronutrients for human health. They are also indispensable to maintaining health and regular operation of organs. Increasing or decreasing these metal ions will lead to cell death, such as ferroptosis. Tsvetkov et al. have recently proposed a novel cell death method called “Cuproptosis”. Many researchers have linked this form of death to the diagnosis, prognosis, microenvironment infiltration, and prediction of immunotherapeutic efficacy of various tumors to better understand these tumors. Similarly, with the proposal of this mechanism, the killing effect of copper ionophores on cancer cells has come to our attention again. We introduced the mechanism of cuproptosis in detail and described the establishment of the corresponding prognostic model and risk score for uveal melanoma through cuproptosis. In addition, we describe the current progress in the study of cancer in other organs through cuproptosis and summarize the treatment of tumours by copper ionophore and its future research direction. With further research, the concept of cuproptosis may help us understand cancer and guide its clinical treatment.
- 13 March 2023
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 478 (12) , 2683-2693
Cuproptosis and its application in different cancers: an overview
Heavy metal ions are essential micronutrients for human health. They are also indispensable to maintaining health and regular operation of organs. Increasing or decreasing these metal ions will lead to cell death, such as ferroptosis. Tsvetkov et al. have recently proposed a novel cell death method called “Cuproptosis”. Many researchers have linked this form of death to the diagnosis, prognosis, microenvironment infiltration, and prediction of immunotherapeutic efficacy of various tumors to better understand these tumors. Similarly, with the proposal of this mechanism, the killing effect of copper ionophores on cancer cells has come to our attention again. We introduced the mechanism of cuproptosis in detail and described the establishment of the corresponding prognostic model and risk score for uveal melanoma through cuproptosis. In addition, we describe the current progress in the study of cancer in other organs through cuproptosis and summarize the treatment of tumours by copper ionophore and its future research direction. With further research, the concept of cuproptosis may help us understand cancer and guide its clinical treatment.
- 8 January 2023
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 478 (9) , 2081-2095
Ferroptosis: mechanisms and advances in ocular diseases
As an essential trace element in the body, iron is critical for the maintenance of organismal metabolism. Excessive iron facilitates reactive oxygen species generation and inflicts damage on cells and tissues. Ferroptosis, a newly identified iron-dependent type of programmed cell death, has been implicated in a broad set of metabolic disorders. Ferroptosis is mainly characterized by excess iron accumulation, elevated lipid peroxides and reactive oxygen species, and reduced levels of glutathione and glutathione peroxidase 4. The vast emerging literature on ferroptosis has shown that numerous diseases, such as cancers, neurodegeneration, and autoimmune diseases, are associated with ferroptosis. Meanwhile, recent studies have confirmed the relationship between ferroptosis and eye diseases including keratopathy, cataract, glaucoma, retinal ischemia-reperfusion injury, age-related macular degeneration, retinitis pigmentosa, diabetic retinopathy, and retinoblastoma, indicating the critical role of ferroptosis in ocular diseases. In this article, we introduce the primary signaling pathways of ferroptosis and review current advances in research on ocular diseases involving iron overload and ferroptosis. Furthermore, several unanswered questions in the area are raised. Addressing these unanswered questions promises to provide new insights into preventing, controlling, and treating not only ocular diseases but also a variety of other diseases in the near future.
- 8 January 2023
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 478 (9) , 2081-2095
Ferroptosis: mechanisms and advances in ocular diseases
As an essential trace element in the body, iron is critical for the maintenance of organismal metabolism. Excessive iron facilitates reactive oxygen species generation and inflicts damage on cells and tissues. Ferroptosis, a newly identified iron-dependent type of programmed cell death, has been implicated in a broad set of metabolic disorders. Ferroptosis is mainly characterized by excess iron accumulation, elevated lipid peroxides and reactive oxygen species, and reduced levels of glutathione and glutathione peroxidase 4. The vast emerging literature on ferroptosis has shown that numerous diseases, such as cancers, neurodegeneration, and autoimmune diseases, are associated with ferroptosis. Meanwhile, recent studies have confirmed the relationship between ferroptosis and eye diseases including keratopathy, cataract, glaucoma, retinal ischemia-reperfusion injury, age-related macular degeneration, retinitis pigmentosa, diabetic retinopathy, and retinoblastoma, indicating the critical role of ferroptosis in ocular diseases. In this article, we introduce the primary signaling pathways of ferroptosis and review current advances in research on ocular diseases involving iron overload and ferroptosis. Furthermore, several unanswered questions in the area are raised. Addressing these unanswered questions promises to provide new insights into preventing, controlling, and treating not only ocular diseases but also a variety of other diseases in the near future.